Hair Loss TreatmentBy: Kris Wheatley
|
Hair Loss Treatment
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
Women's Hair Loss affects as many as 70% of women at some point in their life according to the American Hair Loss Association.
Hair loss forces women to search for treatments to end their hair loss condition and often the only immediate solutions are covering their head with caps, scarves and obvious wigs.
A woman's hair has been called her "Crown and Glory" and naturally the loss of hair is an added stress which takes away from a woman's joy. There are expensive long term hair loss treatments that can cost a woman thousands of dollars and pose health challenges...
The developments made in alternative women's hair loss treatment, such as, human hair lace wigs give women an immediate solution or option that addresses maintaining the aesthetic appearance of a woman, while she researches and makes long term decisions about her hair loss treatment.
The creation of lace wigs as a solution for women's hair loss offers both a temporary and long term solution, and it provides a less dramatic change as a woman can mimic her hair color, texture and style with a lace wig.
The owners of the website, http://www.lacewigswholesaledirect.com focus their talent in creating handmade lace wigs that compliment women faced with hair loss from health conditions, alopecia or their hair falling out.
Hair Loss treatment can be a less stressful experience with the option of wearing a human hair lace wig that looks and feels like your natural hair.
If you are faced with a condition that is causing you hair loss, a lace wig is an option that can make a difference in how you look and feel.
For those who have no idea what exactly a lace wig is and how it can compliment you and alleviate the embarrassment of your hair loss: lace wigs are constructed of human hair that is hand knotted on either French or Swiss lace. The normal time to hand create a human hair lace wig is about 50 hours, and the end result is hair on lace that resembles a natural scalp, is bonded around the circumference of the head, and is worn as your normal hair, even in a ponytail or up-do.
An added benefit is that a lace wig can be worn up to six weeks before needing a fresh bonding. Women can sleep, shower, swim and exercise in their lace wig, it's like having your own hair.
The creation of lace wigs is not new. You may have heard of celebrities wearing hair that was added to provide a full head of hair, length, or just to present a fresh new look for them. Traditionally, lace wigs were expensive with Hollywood Studios paying as much as $19,000 for one lace wig.
The spread of lace wigs to mainstream, presents an option to anyone looking to have a full, healthy head of natural human hair. These lace wigs when originally offered mainstream were created from synthetic hair but as time has gone on many have commanded the very same or near same quality of human hair that celebrities lace wigs are created from...
Beyonce Knowles, Jessica Simpson, Tyra Banks and Rihanna are a few notable celebrities who are known for their fashionable and attractive full lace wigs or front lace wigs and bobs.
So, the option of a lace wig as a solution for women losing their hair, which was once out of reach because of the extremely high cost is now an available solution...
Women facing hair loss deal with stresses naturally but having an immediate solution with lace wigs can maintain your favorable appearance while you decide what you will do long term...
You'll find a wide selection of lace wigs that offer a hair loss solution at: http://www.lacewigswholesaledirect.comhttp://www.lacewigswholesaledirect.com |
|
| Keywords |
hair loss treatment, hair loss remedy, hair falling out, womens hair loss, stress hair loss |
| Category |
Health and Fitness |
| Submission Date |
Sep 14, 2008 |
| Article Contact Name |
Kris Wheatley || send email to Kris Wheatley
|
|
Other links at Health and Fitness |
| 1. |
RNCOS Releases a New Report- Market Potential for Hospital Services, Pharmaceuticals and Medical Dev
|
|
|
RNCOS has recently added a new Market Research Report titled, "Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US" to its report gallery. The US, with its healthcare spending crossing US$ 2.2 Trillion in 2007, represents the most important healthcare product and services market in the world. And according to “Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US”, the new research report from RNCOS, the potential and opportunities in this market are expected to increase several fold in the next five years.
This report provides factual insight supplemented with statistical overview on the past, present and future market. It studies the entire structure, composition and working of the US healthcare sector and describes the potential of hospital services, pharmaceuticals and medical devices in the market. This report discusses the demand, market size and future prospects of nearly every major sector, like cardiovascular, diabetes, musculoskeletal, oncology, wound care management, cosmetic surgery, dental health, and in vitro diagnostics, in the US healthcare market. It identifies key opportunities and roadblocks that will affect the future direction of the market.
“Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US” thus serves as a guide for healthcare service providers/drug manufactures/investors who are planning to enter the US healthcare market as it helps in identifying and analyzing market opportunities that will suit their business needs and profiles.
Key Findings of the Report
- Total healthcare spending in the US is expected to grow at a CAGR of 7% between 2007 and 2012.
- Around 43 Million people are expected to be above 65 years of age in the US by 2012, thereby increasing the prevalence of several chronic diseases.
- Around 122 Million Americans are expected to suffer from cardiovascular diseases by 2012, leading to direct expenses of over US$ 414 Billion.
- The US, with over 19 Million diabetics by 2012, is expected to fuel the growth of the diabetes drugs and monitoring devices market.
- Driven by target-based therapies with negligible side effects, the US oncology market is amongst the fastest growing sectors in the healthcare industry.
- The aging baby boomers, coupled with an increasing incidence of hip and knee fractures, are expected to strongly drive the musckoskeletal market.
- Driven by a need to look young and attractive, both surgical and non-surgical cosmetic procedures are becoming highly popular.
Key Issues & Facts Analyzed in the Report
- Evaluation of past, current and future market trends.
- Market evaluation by type of disease.
- Discussion on the major drivers of the healthcare market.
- Identification and evaluation of the opportunities created by the market.
- Analysis of major challenges for the market.
Research Methodology Used in the Report
Information Sources
Information has been sourced from books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to over 3000 paid databases.
Analysis Methods
RNCOS industry forecast and analysis is based on various macro- and microeconomic factors, sector and industry specific databases, and our in-house statistical and analytical model. This model takes into account the past and current trends in an economy, and more specifically in an industry, to bring out an objective market analysis.
Our industry experts study the relationship between various industry and economic variables to ensure the required accuracy and desired check on the quality of data and information given in the report.
For more information visit: http://www.rncos.com/Report/IM147.htm
Current Industry News: http://www.rncos.com/Blog/
|
| 2. |
RNCOS Releases a New Report- Booming Clinical Trials Market in India
|
|
|
RNCOS has recently added a new Market Research Report titled, “Booming Clinical Trials Market in India” to its report gallery. According to our research report, “Booming Clinical Trials Market in India”, India promises to be one of the hottest destinations for conducting global clinical research, owing to a huge patient pool representing both chronic and infectious diseases, easy recruitment of patients, and high cost savings.
India presently occupies a very small pie of the global opportunity. The total number of clinical trials in India stood at 221 in 2007, which equates to less than 2% of the global clinical trials. With all major pharmaceutical/biotech companies and CROs establishing their presence in India, the number of clinical trials in the country is expected to grow several folds in the next five years. The country is projected to conduct nearly 5% of the global clinical trials by 2012. However, to achieve its goal of becoming a global hub of clinical trials, the country has to overcome challenges like unethical trials, delay in trial approval, inappropriate protection of clinical data, and lack of Good Clinical Practice (GCP) certified sites and investigators.
Surging clinical trials market in India will create enormous opportunities for a number of associated industries, including IVD market, education sector and clinical data management.
“Booming Clinical Trials Market in India” gives an extensive and objective analysis on the Indian clinical trials market. It investigates the advantages/disadvantages India has in becoming a global clinical trials hub. The report exhaustively evaluates and compares the key factors that drug companies and CROs look before outsourcing clinical trials to a country. These include parameters such as patient pool, regulatory environment, cost, infrastructure, human resources and past performance in conducting clinical trials. Thus, this analytical study serves as a useful guide for drug manufacturers, CROs, consultants and investors who are planning to enter the Indian clinical trials market.
Our report provides forecasts on
- Size of global clinical research outsourcing market
- Size of Indian clinical research outsourcing market
- Number of clinical trials in India
- Number of patients expected to participate in clinical trials in India
- Clinical trials infrastructure and professionals in India
- Healthcare indicators in India
Key questions answered in the report
- Why are drug manufacturers outsourcing clinical trials?
- Where and how many clinical trials are being outsourced?
- Where dose India stand in the global clinical trials market?
- How big is the clinical trials opportunity in India?
- How much does it cost on hiring personnel for various clinical research processes, rent and utilities in India as compared to other countries?
- How does clinical trials infrastructure and staff in India vary from other countries?
- What are various government regulations/guidelines for conducting clinical trials in India?
- What are the Future trends predicted to shape the clinical trials market in India?
- How is the clinical trials market impacting associated industries?
Key players analyzed in the report
This section provides business overview on prominent players in the Indian clinical research market like Syngene International Ltd, Quintiles Research (India) Private Limited, Lambda Therapeutic Research Ltd, Vimta Labs Limited and Veeda Clinical Research - India.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM564.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
|
| 3. |
SEO tips to get first rank on google
|
|
|
Getting your website to come up top on Google can be very beneficial for your business. Making a website to come up first on Google is not hard - you just need to know the steps to optimize your website correctly.
SEO (search engine optimization) is the process of improving the volume and quality of the traffic to a website from search engines organic search result listings. Let me share with you some tips to make your website come up first:
1. Clean website coding and architecture. Before you start optimizing your website, you need to have a search engine friendly design. The coding of your website must also be clean so that Google robots can read and understand what your website is about. Avoid using Flash or Frames to build your website as this will prevent Google to read your site properly.
2. Set up internal linking on your website. Internal linking is very important to tell Google which page is important. Therefore, always place text links within your content and point to other important pages on your site. Also, use keywords as your anchor text to increase keyword weight. For example, if you want to point to a page that describes your car rental service, use "car rental service" as the anchor text instead of "click here".
3. Build back links to your website. With more back links pointing to your site, it tells Google that your site is important. Build more back links through article marketing, press release submission, directory submission and social book marking.
4. Post good content on your website. Content is king in SEO. With good content, people will start linking back to your website so that they can share your content with their readers. A website with good content is a link bait and attract lots of back links to your site.
5. Let your site age. The age of your domain name matters when it comes to SEO. Although it is possible for a new website to come up first on Google, older pages are more respected by Google. Especially older pages with high PR (PageRank), it is easier for them to rank high for competitive keywords when compared to newer pages.
SEO is the bed rock of online marketing. Every website should implement SEO right from the beginning. When done right, search engines will bring targeted visitors that will help increase your website conversion.
|
| 4. |
RNCOS Releases a New Report- Japanese Generic Market Forecast to 2013
|
|
|
According to “Japanese Generic Market Forecast to 2013”, a new research report by RNCOS, Japan promises to be one of the most lucrative generic markets in the world. Between 2005 and 2008, the Japanese generics market grew at a CAGR of around 7.5% to register ¥ 333 Billion (US$ 3.5 Billion) in revenue.
The Japanese market is characterized by a strong support by the government, which in a desperate bid to limit its healthcare costs, is introducing a number of generic-friendly policies. Other factors such as a large number of patent expiries and the largely un-penetrated nature of the market are also contributing towards the market growth.
The generic market is presently dominated by domestic manufacturers, with the top six manufacturers accounting for 56% of the total market in 2007. But opening up of the market and introduction of a number of generic-friendly reforms is attracting a number of foreign players in the market.
Despite such a big opportunity for future, the market also has a number challenges to deal with. Generic drugs are still regarded as cheap, low quality alternatives of branded drugs. Thus, both physicians and patients are skeptic regarding their safety and efficacy. A number of awareness and educational programs, however, are expected to increase their awareness in future.
Despite these challenges, our forecast models suggest that the generic drugs market will grow at a CAGR of around 8.8% between 2009 and 2013.
The report gives an extensive and objective analysis on the generic market in Japan. It investigates both the past and present trends in the generic market, but its focus is on the future trends shaping the industry. The report also investigates the performance of various players in the Japanese pharmaceutical and generic markets, and analyzes the competitive landscape in these markets. Based on various present and future indicators, the future scenario of the market has also been analyzed.
Key questions answered in the report
- What is the size and penetration level of the Japanese generic market?
- How is the Japanese generic market different from other developed markets?
- What are the key drivers and challenges for the generic market?
- What is the role of government in the market?
- What is the viewpoint of patients and physicians on generic drugs?
- What is the future outlook of the drug market?
- Who are the key players operating in the Japanese generic market?
Key players operating in Japanese generic market
This report features the key players currently operating in the Japanese pharmaceutical and generic markets. This section describes market shares and growth of key pharmaceutical and generic players in Japan. Profiles of the top six generic manufacturers have been provided in the report.
For more information visit: http://www.rncos.com/Report/IM170.htm
Current Industry News: http://www.rncos.com/Blog/
|
| 5. |
Protocol Link, Inc
|
|
|
Protocol Link, Inc. is a leading global project management and consulting firm offering comprehensive advisory services to regulated life sciences companies worldwide, including regulatory compliance, validation, and quality assurance services.
At Protocol Link, we strive to offer the best of both quality and efficiency. It’s how we’ve been doing business since 1996. The right way. Knowing that our clients are counting on us. We have maintained our track record of doing our very best to get it right the first time, every time, for 11-plus years. 95% of our business represents repeat engagements with satisfied clients, reflecting our client focus.
We offer an even balance of regulatory expertise and experience. Our consultants are hands-on, analytical, yet strategic. We are driven by providing the best solutions to help our clients meet their business goals. With more than 450 projects completed to date, representing engagements in the US, Australia, Belgium, France, Germany, Italy, Japan, Mexico, The Netherlands, Puerto Rico, Romania, and South Korea, Protocol Link is building a strong worldwide presence. Over the years we have successfully managed projects and advised dozens of firms ranging from Fortune 50 companies to start-up biotechnology firms by offering the following list of specialties:
Services Knowledge
Compliance Planning and Management
Compliance and Readiness Audits
Quality Systems Development
Validation (Plans, Systems, Processes)
CGMP / QA Documentation
Regulatory Affairs & Submission Assistance
Technical Services
Training Programs
Exception Investigations and CAPA
FDA and EU Liaison
Inspectional Observations Preparation Critical Systems / Facilities
Computer Systems
SVP and LVP Processes
Solid Dosage Manufacturing
Packaging and Labeling
Cleaning Processes
Analytical Method Development
Laboratory Controls
Diagnostics and Medical Devices
Contract Manufacturing Oversight
Change Control / Change Management
We invite you to visit our Web site at www.protocollink.com for additional information about our company and the services that we offer. We look forward to serving you.
|
|
|
